Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al. Issue 3 (21st March 2023)

Record Type:: Journal Article
Title:: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al. Issue 3 (21st March 2023)
Main Title:: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al
Authors:: Chheda, Zinal S
Mueller, Sabine
Hegde, Bindu
Yamamichi, Akane
Butterfield, Lisa H
Okada, Hideho
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 11:Issue 3(2023)
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 11:Issue 3(2023)
Issue Display:: Volume 11, Issue 3 (2023)
Year:: 2023
Volume:: 11
Issue:: 3
Issue Sort Value:: 2023-0011-0003-0000
Page Start:
Page End:
Publication Date:: 2023-03-21
Subjects:: Antigens, Neoplasm -- Brain Neoplasms -- CD8-Positive T-Lymphocytes -- Immunotherapy -- T-Lymphocytes
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1136/jitc-2022-006617 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26309.xml